Daig, Hermenita .
HRN: 26-74-81 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2025
AMPICILLIN 1GM (VIAL)
05/30/2025
06/02/2025
IV
2 G
Q6
PROM
Waiting Final Action